Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02749617 · OUTCOME

Anti Xa Activity

A Pilot Study Investigating Apixaban and Dexamethasone InterAction in Multiple Myeloma · Source last updated 2021-08-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
3 months

What was measured

serial anti Xa activity

Analysis population: Lack of data.

Groups in this outcome

Apixaban

apixaban 2.5 mg PO BID apixaban: 2.5 mg PO BID

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Apixaban0

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
denoms
  1. counts
    1. group Id
      OG000
      value
      0
    units
    Participants
description
serial anti Xa activity
groups
  1. description
    apixaban 2.5 mg PO BID apixaban: 2.5 mg PO BID
    id
    OG000
    title
    Apixaban
population Description
Lack of data.
reporting Status
POSTED
time Frame
3 months
title
Anti Xa Activity
type
PRIMARY

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice